Abstract
Alzheimer's Disease (AD) provides an excellent case study to investigate emerging conceptions of health, disease, pre-disease, and risk. Two scientific working groups have recently reconceptualized AD and created a new category of asymptomatic biomarker positive persons, who are either said to have preclinical AD, or to be at risk for AD. This article examines how prominent theories of health and disease would classify this condition: healthy or diseased? Next, the notion of being "at risk"- a state somewhere in-between health and disease - is considered from various angles. It is concluded that medical-scientific developments urge us to let go of dichotomous ways of understanding disease, that the notion of "risk,"conceptualized as an increased chance of getting a symptomatic disease, might be a useful addition to our conceptual framework, and that we should pay more attention to the practical usefulness and implications of the ways in which we draw lines and define concepts.
| Original language | English |
|---|---|
| Pages (from-to) | 322-334 |
| Number of pages | 13 |
| Journal | Journal of Medicine and Philosophy |
| Volume | 48 |
| Issue number | 4 |
| Early online date | 18 May 2023 |
| DOIs | |
| Publication status | Published - Aug 2023 |
Bibliographical note
Funding Information: The research for this article was supported by the Nederlandse Organisatie voor Wetenschappelijk Onderzoek (Netherlands Organisation for Health Research and Development, ZonMW)Publisher Copyright: © 2023 The Author(s). Published by Oxford University Press on behalf of the Journal of Medicine and Philosophy Inc.
Fingerprint
Dive into the research topics of 'Preclinical Disease or Risk Factor? Alzheimer's Disease as a Case Study of Changing Conceptualizations of Disease'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver